LAKE OSWEGO, Ore., Feb. 17, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled, "From Promise to Products: Clinical and Regulatory Approaches for Targeted Immunotherapy Development" at the 2nd Annual Emerging Targeted Oncology Partnering Forum. The presentation will take place on Sunday, February 19, 2012 at 5:00 PM PST at the InterContinental Hotel in San Francisco, CA.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647